A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects
- PMID: 20453030
- PMCID: PMC2943616
- DOI: 10.1093/nar/gkq341
A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects
Abstract
Small interfering RNAs (siRNAs) are now established as the preferred tool to inhibit gene function in mammalian cells yet trigger unintended gene silencing due to their inherent miRNA-like behavior. Such off-target effects are primarily mediated by the sequence-specific interaction between the siRNA seed regions (position 2-8 of either siRNA strand counting from the 5'-end) and complementary sequences in the 3'UTR of (off-) targets. It was previously shown that chemical modification of siRNAs can reduce off-targeting but only very few modifications have been tested leaving more to be identified. Here we developed a luciferase reporter-based assay suitable to monitor siRNA off-targeting in a high throughput manner using stable cell lines. We investigated the impact of chemically modifying single nucleotide positions within the siRNA seed on siRNA function and off-targeting using 10 different types of chemical modifications, three different target sequences and three siRNA concentrations. We found several differently modified siRNAs to exercise reduced off-targeting yet incorporation of the strongly destabilizing unlocked nucleic acid (UNA) modification into position 7 of the siRNA most potently reduced off-targeting for all tested sequences. Notably, such position-specific destabilization of siRNA-target interactions did not significantly reduce siRNA potency and is therefore well suited for future siRNA designs especially for applications in vivo where siRNA concentrations, expectedly, will be low.
Figures






Similar articles
-
5' Unlocked Nucleic Acid Modification Improves siRNA Targeting.Mol Ther Nucleic Acids. 2013 Jul 2;2(7):e103. doi: 10.1038/mtna.2013.36. Mol Ther Nucleic Acids. 2013. PMID: 23820891 Free PMC article.
-
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo.Mol Biosyst. 2010 May;6(5):862-70. doi: 10.1039/b918869j. Epub 2010 Feb 9. Mol Biosyst. 2010. PMID: 20567772
-
Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.Mol Ther. 2011 Sep;19(9):1676-87. doi: 10.1038/mt.2011.109. Epub 2011 Jun 14. Mol Ther. 2011. PMID: 21673662 Free PMC article.
-
Chemical modification of siRNA.Curr Opin Mol Ther. 2010 Apr;12(2):158-67. Curr Opin Mol Ther. 2010. PMID: 20373259 Review.
-
Recent progress in chemically modified siRNAs.Mini Rev Med Chem. 2010 Jun;10(7):578-95. doi: 10.2174/138955710791384036. Mini Rev Med Chem. 2010. PMID: 20500149 Review.
Cited by
-
Improved siRNA/shRNA functionality by mismatched duplex.PLoS One. 2011;6(12):e28580. doi: 10.1371/journal.pone.0028580. Epub 2011 Dec 9. PLoS One. 2011. PMID: 22174840 Free PMC article.
-
Developing the Strategy to Use Silk Spheres for Efficient, Targeted Delivery of Oligonucleotide Therapeutics to Cancer Cells.Int J Nanomedicine. 2025 Jun 23;20:8023-8039. doi: 10.2147/IJN.S519906. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40584785 Free PMC article.
-
Action and reaction: the biological response to siRNA and its delivery vehicles.Mol Ther. 2012 Mar;20(3):513-24. doi: 10.1038/mt.2011.294. Epub 2012 Jan 17. Mol Ther. 2012. PMID: 22252451 Free PMC article. Review.
-
Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2.Silence. 2011 Mar 14;2:3. doi: 10.1186/1758-907X-2-3. Silence. 2011. PMID: 21401928 Free PMC article.
-
Rational design of therapeutic siRNAs: minimizing off-targeting potential to improve the safety of RNAi therapy for Huntington's disease.Mol Ther. 2011 Dec;19(12):2169-77. doi: 10.1038/mt.2011.185. Epub 2011 Sep 27. Mol Ther. 2011. PMID: 21952166 Free PMC article.
References
-
- Dykxhoorn DM, Lieberman J. RUNNING INTERFERENCE: prospects and obstacles to using small interfering RNAs as small molecule drugs. Annu. Rev. Biomed. Eng. 2006;8:377–402. - PubMed
-
- Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494–498. - PubMed
-
- Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell. 2005;123:607–620. - PubMed
-
- Rand TA, Petersen S, Du F, Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell. 2005;123:621–629. - PubMed
-
- Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005;11:263–270. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources